Stocks · Health care · Pharmaceutical Preparations

MANNKIND CORP

MNKD Clue Score45
United States Fiscal year ends December CIK 0000899460 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Michael Castagna
29 Aug 2024
Chief Executive Officer
Sell
85,106
$6.30
$536.17K
Michael Castagna
15 Dec 2023
Chief Executive Officer
Sell
90,482
$4.00
$361.93K
Michael Castagna
14 Dec 2023
Chief Executive Officer
Sell
100,000
$4.00
$400.00K
Michael Castagna
14 Dec 2023
Chief Executive Officer
Sell
10,000
$4.00
$40.00K
Michael Castagna
1 Nov 2023
Chief Executive Officer
Sell
10,000
$4.25
$42.50K
Michael Castagna
2 Oct 2023
Chief Executive Officer
Sell
10,000
$4.61
$46.10K
Michael Castagna
1 Sep 2023
Chief Executive Officer
Sell
10,000
$4.61
$46.10K
Steven B. Binder
24 May 2023
Chief Financial Officer
Sell
47,810
$4.68
$223.51K
Michael Castagna
24 May 2023
Chief Executive Officer
Sell
150,000
$4.69
$702.78K
David Thomson
24 May 2023
EVP Genl Counsel & Secretary
Sell
95,576
$4.68
$447.75K
Michael Castagna
3 Apr 2023
Chief Executive Officer
Sell
10,000
$4.13
$41.29K
Michael Castagna
1 Mar 2023
Chief Executive Officer
Sell
10,000
$5.27
$52.75K
David Thomson
29 Aug 2022
EVP Genl Counsel & Secretary
Sell
7,000
$3.67
$25.69K
Alejandro Galindo
22 Aug 2022
EVP Endocrine Business Unit
Sell
15
$3.84
$57.60
Alejandro Galindo
22 Aug 2022
EVP Endocrine Business Unit
Sell
4,600
$3.85
$17.71K
David Thomson
27 Aug 2021
EVP Genl Counsel & Secretary
Sell
4,100
$4.64
$19.02K
Raymond W. Urbanski
10 Aug 2017
Corp VP, CMO
Sell
296
$1.15
$340.40

What was left out

Form 4 filings counted 390
Amendments (4/A) skipped 32
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 36
Sales straight out of an exercise 7
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 20,580,059
Sales filed before the plan box existed 6
History held since 17 Oct 2006